These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36836085)

  • 1. Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients.
    Lee WT; Fang YW; Chen M; Liou HH; Lee CJ; Tsai MH
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis.
    Fang YW; Wang JT; Lin TY; Lee CJ; Jang TN; Tsai MH; Liou HH
    Front Med (Lausanne); 2023; 10():1098871. PubMed ID: 37081846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Clearance of Fibroblast Growth Factor-23 (FGF23) and its Fragments in Humans.
    Sharma S; Katz R; Ginsberg C; Bullen A; Vallon V; Thomson S; Moe OW; Hoofnagle AN; de Leeuw PW; Kroon AA; Houben AJHM; Ix JH
    J Bone Miner Res; 2022 Jun; 37(6):1170-1178. PubMed ID: 35373859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphate control in reducing FGF23 levels in hemodialysis patients.
    Rodelo-Haad C; Rodríguez-Ortiz ME; Martin-Malo A; Pendon-Ruiz de Mier MV; Agüera ML; Muñoz-Castañeda JR; Soriano S; Caravaca F; Alvarez-Lara MA; Felsenfeld A; Aljama P; Rodriguez M
    PLoS One; 2018; 13(8):e0201537. PubMed ID: 30086150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
    Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of FGF-23 With Biochemical Markers and Bone Density in Chronic Kidney Disease-Bone Mineral Density Disorder.
    Hussain I; Tandi R; Singh G; Kaur G; Abhishek ; Dodda S; Patel D; Natarajan B; Maram T; Kedia A; Vempati R; Sahu S; Choubey U
    Cureus; 2023 Jan; 15(1):e33879. PubMed ID: 36812096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Fgf23 and Balp with Bone Mineral Density in Hemodialysis Patients.
    Bouksila M; Mrad M; Kaabachi W; Kalai E; Smaoui W; Rekik S; Krir A; Issaoui N; Hamzaoui K; Sahli H; Kateb ECE; Zouaghi MK; Bahlous A
    J Med Biochem; 2019 Oct; 38(4):418-426. PubMed ID: 31496905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.
    van Breda F; Emans ME; van der Putten K; Braam B; van Ittersum FJ; Kraaijenhagen RJ; de Borst MH; Vervloet M; Gaillard CA
    PLoS One; 2015; 10(6):e0128994. PubMed ID: 26079688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients.
    Gao S; Xu J; Zhang S; Jin J
    Blood Purif; 2019; 47 Suppl 1(Suppl 1):24-30. PubMed ID: 30699419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women.
    Imel EA; Liu Z; McQueen AK; Acton D; Acton A; Padgett LR; Peacock M; Econs MJ
    Bone; 2016 May; 86():98-105. PubMed ID: 26965530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of Fibroblast Growth Factor 23 as a Cardiovascular Risk Predictor in Chronic Kidney Disease Weaken by ProBNP Adjustment.
    Emrich IE; Brandenburg V; Sellier AB; Schauerte J; Wiedenroth J; Untersteller K; Lennartz CS; Seiler-Mussler S; Wagenpfeil S; Fliser D; Heine GH
    Am J Nephrol; 2019; 49(3):203-211. PubMed ID: 30808827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher Fibroblast Growth Factor 23 Levels Are Causally Associated With Lower Bone Mineral Density of Heel and Femoral Neck: Evidence From Two-Sample Mendelian Randomization Analysis.
    Wang Y; Wang H; Chen P
    Front Public Health; 2020; 8():467. PubMed ID: 32984251
    [No Abstract]   [Full Text] [Related]  

  • 14. The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans.
    Bielesz B; Reiter T; Hammerle FP; Winnicki W; Bojic M; Gleiss A; Kieweg H; Ratzinger F; Sunder-Plassmann G; Marculescu R
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32823844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival.
    Chu C; Elitok S; Zeng S; Xiong Y; Hocher CF; Hasan AA; Krämer BK; Hocher B
    BMC Nephrol; 2021 Apr; 22(1):125. PubMed ID: 33832449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.
    Hanudel MR; Wesseling-Perry K; Gales B; Ramos G; Campbell V; Ethridge K; Scotti M; Elashoff DA; Alejos J; Reemtsen B; Salusky IB
    Pediatr Nephrol; 2016 Apr; 31(4):661-9. PubMed ID: 26525200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 and Klotho serum levels in healthy children.
    Gkentzi D; Efthymiadou A; Kritikou D; Chrysis D
    Bone; 2014 Sep; 66():8-14. PubMed ID: 24880094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.
    Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C
    Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.
    Tartaglione L; Pasquali M; Rotondi S; Muci ML; Leonangeli C; Farcomeni A; Fassino V; Mazzaferro S
    PLoS One; 2017; 12(5):e0178637. PubMed ID: 28558021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Supplementation for 12 Months in Older Adults Alters Regulators of Bone Metabolism but Does Not Change Wnt Signaling Pathway Markers.
    Christodoulou M; Aspray TJ; Piec I; Washbourne C; Tang JC; Fraser WD; Schoenmakers I;
    JBMR Plus; 2022 May; 6(5):e10619. PubMed ID: 35509637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.